Medicare Part B

Market Access

Hogan Lovells partner Alice Valder Curran returned to elucidate some of the finer points of the latest communication from CMS.

News

BMS' arlo-cel has shown activity in a trial that could underpin filings in multiple myeloma settings where the four main drug classes have failed.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.